WO2006096648A3 - Modele de souris - Google Patents

Modele de souris Download PDF

Info

Publication number
WO2006096648A3
WO2006096648A3 PCT/US2006/007941 US2006007941W WO2006096648A3 WO 2006096648 A3 WO2006096648 A3 WO 2006096648A3 US 2006007941 W US2006007941 W US 2006007941W WO 2006096648 A3 WO2006096648 A3 WO 2006096648A3
Authority
WO
WIPO (PCT)
Prior art keywords
mice
relates
present
well
targeting vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/007941
Other languages
English (en)
Other versions
WO2006096648A2 (fr
Inventor
Nanda A Singh
Mark F Leppert
H Steve White
Karen S Wilcox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation Inc
Original Assignee
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation Inc filed Critical University of Utah Research Foundation Inc
Publication of WO2006096648A2 publication Critical patent/WO2006096648A2/fr
Publication of WO2006096648A3 publication Critical patent/WO2006096648A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0356—Animal model for processes and diseases of the central nervous system, e.g. stress, learning, schizophrenia, pain, epilepsy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention concerne des souris transgéniques, en particulier des souris knock-in (avec insertion d'un gène actif), qui présentent des mutations dans le gène KCNQ2 ou dans le gène KCNQ3, ainsi que le sperme de ces souris. Cette invention concerne également des vecteurs de ciblage conçus pour créer de telles souris. Elle concerne aussi des cellules souches embryonnaires de souris et du sperme cryoconservé comprenant lesdits vecteurs de ciblage, ainsi qu'un procédé de criblage permettant d'identifier des composés utilisés pour traiter des pathologies physiologiques humaines, telles que les convulsions néonatales familiales bénignes (BFNC), les épilepsies partielles, les épilepsies à résistance thérapeutique, les migraines, les douleurs neuropathiques, les accidents vasculaires cérébraux, la démence et l'anxiété.
PCT/US2006/007941 2005-03-07 2006-03-07 Modele de souris Ceased WO2006096648A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65856905P 2005-03-07 2005-03-07
US60/658,569 2005-03-07

Publications (2)

Publication Number Publication Date
WO2006096648A2 WO2006096648A2 (fr) 2006-09-14
WO2006096648A3 true WO2006096648A3 (fr) 2007-07-05

Family

ID=36953935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/007941 Ceased WO2006096648A2 (fr) 2005-03-07 2006-03-07 Modele de souris

Country Status (1)

Country Link
WO (1) WO2006096648A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2390348A1 (fr) * 2010-05-25 2011-11-30 Sanofi Procédés et utilisations liées à l'identification d'un composé impliqué dans la douleur et procédés pour le diagnostic de l'algésie
EP2390349A1 (fr) * 2010-05-25 2011-11-30 Sanofi Procédés et utilisations liées à l'identification d'un composé impliqué dans la douleur et procédés pour le diagnostic de l'algésie
WO2025137828A1 (fr) * 2023-12-25 2025-07-03 中国科学院深圳先进技术研究院 Procédé de construction de modèle de souris à mutation ponctuelle de gène

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413719B1 (en) * 1997-10-24 2002-07-02 University Of Utah Research Foundation KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies
US6794161B1 (en) * 1999-01-26 2004-09-21 Neurosearch A/S Potassium channels and genes encoding these potassium channels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6413719B1 (en) * 1997-10-24 2002-07-02 University Of Utah Research Foundation KCNQ2 and KCNQ3-potassium channel genes which are mutated in benign familial neonatal convulsions (BFNC) and other epilepsies
US6794161B1 (en) * 1999-01-26 2004-09-21 Neurosearch A/S Potassium channels and genes encoding these potassium channels

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DEL GIUDICE E.M. ET AL.: "Benign family neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor", EUROPEAN JOURNAL OF HUMAN GENETICS, vol. 8, no. 12, December 2000 (2000-12-01), pages 994 - 997, XP003015158 *
PETERS H.C. ET AL.: "Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior", NATURE NEUROSCIENCE, vol. 8, no. 1, January 2005 (2005-01-01), pages 51 - 60, XP003015160 *
SINGH N.A. ET AL.: "KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum", BRAIN, vol. 126, no. 12, October 2003 (2003-10-01), pages 2726 - 2737, XP003015159 *

Also Published As

Publication number Publication date
WO2006096648A2 (fr) 2006-09-14

Similar Documents

Publication Publication Date Title
NO20083743L (no) Pyrimidinylsulfonamidforbindelser som inhiberer leukocyttadhesjon mediert av VLA-4
IL190665B (en) Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
WO2006124897A3 (fr) Procedes et compositions d'amelioration de la cognition
EP1852428A4 (fr) Compose 4-cyclopropyl-1,2,3-thiadiazole, agent de lutte contre les maladies des plantes issues d'agrohorticulture et procede l utilisant
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
IL188330A (en) Processes for the preparation of 4-amino-2- (6,2-dioxofipridine-3-il) compounds isoindoline-1,3-dion
WO2009085200A3 (fr) Anticorps anti-amyloïde et utilisations de ceux-ci
WO2008121199A3 (fr) Modèles d'animaux transgéniques pour une maladie
WO2007060247A3 (fr) Préparations d'enzymes au goût agréable
WO2010011283A3 (fr) Composés à base de fus/tls et méthodes de diagnostic, traitement et prévention d'une sclérose latérale amyotrophique et de maladies des motoneurones apparentées
DK1940826T3 (da) Pyrimidinylamidforbindelser, der inhiberer leukocytadhæsion medieret gennem BLA-4
WO2007109107A3 (fr) Atf4 utilisé comme cible thérapeutique dans la maladie d'alzheimer et autres troubles neurologiques
DE602006019468D1 (de) Diarylharnstoffe zur behandlung von pulmonaler hypertonie
BRPI0908308A2 (pt) "cepa h. Polymorpha, processo para a fabricação de etanol e ácido nucléico recombinante"
WO2006096648A3 (fr) Modele de souris
PL1926369T3 (pl) Zastosowanie estrów mleczanów do poprawy działania środków ochrony roślin
WO2009015369A3 (fr) Composés qui inhibent l'activité de la bêta-sécrétase et procédés d'utilisation de ceux-ci
WO2008011484A3 (fr) Désensibilisateurs nicotiniques et procédés pour les sélectionner, les tester et les utiliser
WO2006034296A3 (fr) Composes amino inhibant l'activite de la beta-secretase et methodes d'utilisation
WO2004078939A3 (fr) Regulation de la fonction mdm2
WO2007056435A3 (fr) Maladies mediees par la dynamine et procedes et produits associes
WO2003026395A3 (fr) Disruptions geniques mo54, compositions et procedes correspondants
EP1848819A4 (fr) Procedes d'analyse genetique comprenant l'amplification de duplicons complementaires
NO20021146D0 (no) Polymorfier i de humane CYP3A4- og CYP3A7-genene og deres anvendelse i diagnostiske og terapeutiske anvendelser
WO2006132739A3 (fr) Nouveaux composes chimiques

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06737156

Country of ref document: EP

Kind code of ref document: A2